NACSYS® COST SAVINGS CALCULATOR

NACSYS is part of the ALTURiX Medicines Value Programme, which is designed to help reduce local prescribing budgets.

4 or 52 weeks?

This model compares NACSYS with carbocisteine, in terms of cost. The recommended licensed initial dose of carbocisteine is 2,250mg daily, reducing to 1,500mg daily when a satisfactory response is obtained. The user can select a short initiation dose period (of 4 weeks) or continuation of this higher dose for a full 52 weeks. These are intended for illustrative scenarios only. Please contact us for alternative scenarios tailored to your locality.

Percentage conversions

The user can select one of four conversion scenarios. These are intended for illustrative scenarios only. Please contact us for alternative scenarios tailored to your locality.
Calculate Savings
{!calculation.nacsys.result.formatted.diff!}
Potential savings are calculated for {!calculation.nacsys.result.pco!} and are based on all carbocisteine patients being on the high dose for {!calculation.nacsys.result.weeks!} weeks, and conversion of {!calculation.nacsys.result.percent!}% of all patients to NACSYS. Please change these settings for alternative scenarios.
Change Settings
{!calculation.nacsys.result.formatted.before!}
{!calculation.nacsys.result.formatted.after!}
  • {!calculation.nacsys.result.formatted.before!}
  • {!calculation.nacsys.result.formatted.after!}
  • {!calculation.nacsys.result.formatted.diff!}